首次临床研究:利用18F-FAPI-42 PET/CT参数预测胃癌淋巴血管和/或神经周围侵犯
研究纳入72例术前接受18F-FAPI-42 PET/CT的胃癌患者,比较LVI/PNI阴性与阳性组的临床病理因素和PET参数。SUVmax、SUVmean和TBR均与LVI/PNI状态显著相关(均p<0.001),预测AUC分别为0.932、0.923和0.925。多因素分析显示组织学分级和SUVmax是独立危险因素,列线图AUC为0.934。
要点
- SUVmax、SUVmean和TBR与胃癌LVI/PNI状态显著相关(均p<0.001)。
- SUVmax预测LVI/PNI的AUC为0.932,最佳截断值3.86,敏感度93.3%、特异度81.5%。
- 组织学分级和SUVmax是LVI/PNI的独立危险因素,列线图AUC为0.934。
核心结论
- FAPI摄取参数对预测胃癌LVI/PNI状态表现出极高的能力,可作为无创术前工具,其中SUVmax是最合适的预测指标。
研究设计与样本
- 纳入72例术前接受18F-FAPI-42 PET/CT、随后行手术切除的胃癌患者,比较LVI/PNI阴性与阳性组的临床病理因素和PET参数。
- 采用受试者工作特征(ROC)曲线评估PET参数对LVI/PNI状态的预测价值。
- 基于多因素逐步回归分析中的显著预测因子构建列线图,并用决策曲线分析(DCA)评估其性能。
主要发现
- 单因素分析显示LVI/PNI状态与PET参数(SUVmax、SUVmean和TBR)显著相关(均p<0.001)。
- 预测LVI/PNI的AUC:SUVmax为0.932 [95%CI (0.877-0.987)],SUVmean为0.923 [95%CI (0.861-0.984)],TBR为0.925 [95%CI (0.865-0.985)]。
- 最佳截断值及对应敏感度和特异度:SUVmax为3.86(93.3%和81.5%),SUVmean为2.04(93.3%和81.5%),TBR为9.75(91.1%和81.5%)。
- 多因素分析确定组织学分级和SUVmax是预测LVI/PNI的独立危险因素。
- 列线图具有良好区分能力(AUC=0.934),DCA显示在预测LVI/PNI状态方面提供净获益。
关键数值与推荐
- SUVmax预测LVI/PNI的AUC为0.932 [95%CI (0.877-0.987)],最佳截断值3.86,敏感度93.3%、特异度81.5%。
- SUVmean预测LVI/PNI的AUC为0.923 [95%CI (0.861-0.984)],最佳截断值2.04,敏感度93.3%、特异度81.5%。
- TBR预测LVI/PNI的AUC为0.925 [95%CI (0.865-0.985)],最佳截断值9.75,敏感度91.1%、特异度81.5%。
- 列线图预测LVI/PNI的AUC为0.934。
临床怎么用
- 作者认为FAPI摄取参数可作为无创术前工具预测胃癌LVI/PNI状态,SUVmax为最合适的预测指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was conducted to explore the predictive value of PET parameters derived from 18F-FAPI-42 PET/CT in assessing lymphovascular and/or perineural invasion (LVI/PNI) in gastric cancer (GC) patients. METHODS: 72 GC patients who underwent 18F-FAPI-42 PET/CT prior to surgical resection were included. Clinicopathological factors and PET parameters were collected and analyzed in LVI/PNI-negative and LVI/PNI-positive groups. The predictive value of PET parameters for LVI/PNI status was evaluated using the receiver operating characteristic (ROC) curve. A nomogram was developed using significant predictors from multivariate stepwise regression analysis and its performance was assessed by decision curve analysis (DCA). RESULTS: Univariate analysis indicated a significant association between LVI/PNI status and PET parameters (SUVmax, SUVmean, and TBR) (all p < 0.001). The area under the ROC curve (AUC) values for predicting LVI/PNI were 0.932 [95% CI (0.877-0.987)] for SUVmax, 0.923 [95% CI (0.861-0.984)] for SUVmean, and 0.925 [95% CI (0.865-0.985)] for TBR. The optimal cutoff values for prediction, along with their corresponding sensitivity and specificity, were 3.86 (93.3% and 81.5%) for SUVmax, 2.04 (93.3% and 81.5%) for SUVmean, and 9.75 (91.1% and 81.5%) for TBR. Multivariate analysis identified histological grade and SUVmax as independent risk factors for LVI/PNI prediction. Our nomogram had good discriminatory ability (AUC = 0.934) and offered net benefits in predicting LVI/PNI status by DCA. CONCLUSION: This study demonstrates that FAPI uptake parameters exhibit an exceptionally high capacity and serve as a noninvasive preoperative tool for predicting LVI/PNI status in GC, with SUVmax emerging as the most suitable predictive indicator.
引用
- Fu L, Xie F, Sun P, et al. First clinical investigation to predict lymphovascular and/or perineural invasion in gastric cancer using 18F-FAPI-42 PET/CT parameters. Eur J Nucl Med Mol Imaging. 2025. PMID: 40387910. doi:10.1007/s00259-025-07325-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。